SAN DIEGO, Feb. 26, 2020 /PRNewswire/ -- Halozyme
Therapeutics, Inc. (NASDAQ: HALO) will be presenting at the Cowen
and Company 40th Annual Health Care Conference on Wednesday, March 4 at 11:20 a.m. ET / 8:20 a.m.
PT in Boston. Dr.
Helen Torley, president and chief
executive officer, will provide a corporate overview.
The presentation will be webcast through the "Investors" section
of Halozyme's corporate website at www.halozyme.com, and a
recording will be made available for 90 days following the event.
To access a live webcast, please visit Halozyme's website
approximately 15 minutes prior to the presentation to register and
download any necessary audio software.
About Halozyme
Halozyme Therapeutics Inc. is a biopharma technology platform
company that provides innovative and disruptive solutions with the
goal of improving patient experience and outcomes. Our proprietary
enzyme rHUPH20 is used to facilitate the delivery of injected drugs
and fluids. We license our technology to biopharmaceutical
companies to collaboratively develop products that combine our
ENHANZE® drug delivery technology with the collaborators'
proprietary compounds. Halozyme is headquartered in San Diego. For more information visit
www.halozyme.com.
Contact:
Al
Kildani
Vice President, Investor Relations and Corporate Communications
858-704-8122
ir@halozyme.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/halozyme-therapeutics-to-present-at-the-cowen-40th-annual-health-care-conference-301011984.html
SOURCE Halozyme Therapeutics, Inc.